Asked by: Baroness Tonge (Non-affiliated - Life peer)
Question to the Department for Business, Energy and Industrial Strategy:
To ask Her Majesty's Government what assessment they have made, if any, of the environmental impact of the proposed plan by the Europe Asia Pipeline Company to store and transport oil and distillates from the UAE to Europe.
Answered by Lord Callanan - Shadow Minister (Foreign, Commonwealth and Development Office)
We welcome the normalisation of relations between Israel and the United Arab Emirates. We are aware of the preliminary agreement subsequently announced on 20 October between companies in both countries to collaborate in the storage and transfer of oil and oil products through the Europe Asia Pipeline Company’s (EAPC) infrastructure. Her Majesty’s Government is not a party to this commercial deal.
Asked by: Baroness Tonge (Non-affiliated - Life peer)
Question to the Department for Business, Energy and Industrial Strategy:
To ask Her Majesty's Government what proportion of the Department for Business, Energy and Industrial Strategy budget is spent on (1) family planning, (2) sexual and reproductive health and rights, and (3) population issues, in the developing world.
Answered by Lord Henley
The Global Challenges Research Fund (GCRF) mainly supports projects where the benefits are to multiple countries. In 2016, the latest date for which figures are available, 92.4% of GCRF spend was reported as non-country specific ODA spend with no single benefitting country. Of the remaining 7.6%, the highest spend was assigned to regional projects in Africa and to Tanzania, Cote D’Ivoire, South Africa, Guatemala and Peru.
In 2016, 12% of GCRF spend was categorised as “Medical Research”, we do not hold data on subcategories within this area.
Asked by: Baroness Tonge (Non-affiliated - Life peer)
Question to the Department for Business, Energy and Industrial Strategy:
To ask Her Majesty's Government what countries receive Official Development Assistance through the Global Challenges Research Fund.
Answered by Lord Henley
The Global Challenges Research Fund (GCRF) mainly supports projects where the benefits are to multiple countries. In 2016, the latest date for which figures are available, 92.4% of GCRF spend was reported as non-country specific ODA spend with no single benefitting country. Of the remaining 7.6%, the highest spend was assigned to regional projects in Africa and to Tanzania, Cote D’Ivoire, South Africa, Guatemala and Peru.
In 2016, 12% of GCRF spend was categorised as “Medical Research”, we do not hold data on subcategories within this area.
Asked by: Baroness Tonge (Non-affiliated - Life peer)
Question to the Department for Business, Energy and Industrial Strategy:
To ask Her Majesty's Government what proportion of the Global Challenges Research Fund is spent on (1) family planning, (2) sexual and reproductive health and rights, and (3) population issues, in the developing world.
Answered by Lord Henley
The Global Challenges Research Fund (GCRF) mainly supports projects where the benefits are to multiple countries. In 2016, the latest date for which figures are available, 92.4% of GCRF spend was reported as non-country specific ODA spend with no single benefitting country. Of the remaining 7.6%, the highest spend was assigned to regional projects in Africa and to Tanzania, Cote D’Ivoire, South Africa, Guatemala and Peru.
In 2016, 12% of GCRF spend was categorised as “Medical Research”, we do not hold data on subcategories within this area.
Asked by: Baroness Tonge (Non-affiliated - Life peer)
Question to the Department for Business, Energy and Industrial Strategy:
To ask Her Majesty’s Government what funding they give to the International Atomic Energy Authority for the prevention and treatment of cancer in low- and middle-income member states.
Answered by Lord Prior of Brampton
The UK makes annual contributions to the International Atomic Energy Agency’s (IAEA) Technical Cooperation Fund. In financial year 2016-2017 the UK contributed just over £3.1 million to the fund. This fund delivers a range of development projects including, but not limited to, those that build human and technical capacity to diagnose and treat cancer, and those that promote and support improved access to quality cancer treatment services for local populations.
The UK also supports the Programme of Action for Cancer Therapy (PACT) – which provides comprehensive cancer care to low- and middle-income countries worldwide – as one of a wide range of IAEA activities funded through the UK’s annual payments to the IAEA’s Regular Budget.